China Health Technology Group Holding Co (HKSE:01069) ROCE % : 2.75% (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Health Technology Group Holding Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Health Technology Group Holding Co's annualized ROCE % for the quarter that ended in Jun. 2024 was 2.75%.

China Health Technology Group Holding Co ROCE % Historical Data

The historical data trend for China Health Technology Group Holding Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Technology Group Holding Co ROCE % Chart

China Health Technology Group Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

-31.70

-43.54

China Health Technology Group Holding Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															-	-	-	2.75	9.53

China Health Technology Group Holding Co ROCE % Calculation

China Health Technology Group Holding Co's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	218.806	/	( ( (153.833 - 484.429)	+	(191.803 - 53.09) )	/ 2 )
	=	218.806	/	( (-330.596	+	138.713)	/ 2 )
	=	218.806	/	-95.9415
	=	-228.06 %

China Health Technology Group Holding Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	3.822	/	( ( (154.702 - 15.949)	+	(191.803 - 53.09) )	/ 2 )
	=	3.822	/	( ( 138.753	+	138.713 )	/ 2 )
	=	3.822	/	138.733
	=	2.75 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

China Health Technology Group Holding Co (HKSE:01069) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China Health Technology Group Holding Co ROCE % Related Terms

Thank you for viewing the detailed overview of China Health Technology Group Holding Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Technology Group Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » China Health Technology Group Holding Co Ltd (HKSE:01069) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Binhe Road South, Room 4101, Phase II Jingji Binhe Shidai Tower North, Futian District, Shenzhen, CHN

Website

http://www.caflc.co

China Health Technology Group Holding Co Ltd Formerly China Bozza Development Holdings Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has two reportable segments including the Forestry business; Horny Goat Weed Business; and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.

Executives

Huang Hou	2201 Interest of corporation controlled by you
Huang Hou	2101 Beneficial owner
Able Planet International Limited
China Bozza Scheme Limited
Arab Osman Mohammed
Lai Wing Lun
Wang Yue	2101 Beneficial owner
Long Yijia	2202 Interest of your spouse

China Health Technology Group Holding Co Headlines

No Headlines